Fidelity International’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-208
Closed -$10K 1128
2020
Q4
$10K Sell
208
-3,376,211
-100% -$157M ﹤0.01% 811
2020
Q3
$157M Hold
3,376,419
0.2% 138
2020
Q2
$122M Buy
3,376,419
+151,118
+5% +$5.57M 0.16% 151
2020
Q1
$114M Buy
3,225,301
+1,608,522
+99% +$65.8M 0.19% 125
2019
Q4
$73.5M Buy
+1,616,779
New +$58.7M 0.1% 212

Other funds holding ZYME

Fidelity International's ZYME Position: Q1 2021 in Review

Fidelity International sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 208 shares — an estimated $10K sold.

Fidelity International first reported a position in ZYME in Q4 2019 and held it in 5 quarters. The position peaked at $157M in Q3 2020. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.

  • Fidelity International reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
  • Fidelity International sold 208 Zymeworks shares in Q1 2021, an estimated $10K.
  • Fidelity International first reported a position in Zymeworks in Q4 2019 and held it in 5 quarters.
  • Fidelity International's Zymeworks position peaked at $157M in Q3 2020.
  • 125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.

Based on Fidelity International's 13F filing for Q1 2021, filed 14 May 2021.